Advent Health recap

From today's "Inside Baseball" edition via email from Jarrard Phillips Cate & Hancock, the Nashville healthcare public communications firm (not yet posted here), in part, "A small circle of Nashville heavy hitters – Fred Goad (investor through Voyent Partners and founder of Envoy Corp.), Joel Gordon (local investor, former head of HealthSouth and co-founder of Surgical Care Affiliates), Jim Sohr (local investor and former head of AIM Healthcare) and Dave Swenson (investor through SSM Ventures and Coleman, Swenson & Booth ) just to name a few – have a big deal in the works [...] to recapitalize Chicago-based Advent Health Partners, a revenue cycle management company..."

edo Interactive names Jim Kever chairman

edo Interactive, long led by CEO Ed Braswell (left) and backed by VC Claritas and others, has named Envoy founder, entrepreneur and superangel (with Fred Goad in Voyent Partners) Jim Kever chairman of its board. The release is here. The company recently named Clay Whitson, former as iPayment, as its CFO.

Emdeon technivore?

Assuming Emdeon eventually hits the button on its prospective initial public offering of common stock, the company is likely to continue its acquisitive ways. Last week's Emdeon announcement of its acquisition of eRx Network came three years after the pair entered a strategic alliance. Within the past ten months, Emdeon also announced its acquisition of GE Healthcare Information Technology's patient-statement business; and, its purchase of The Sentinel Group, a fraud- and abuse-management services provider. With that in mind, we note that within the past 15 months Emdeon also announced strategic alliances with Durham-based Bloodhound Partner (Optimal Business-Trustmark Holdings), a claims analytics provider; and, consummated a tech partnership with drug-claims tech provider NovoLogix (then known as ACM Inc.), based in Minneapolis. The flurry of activity in 2008, followed by a few weeks the purchase by Emdeon's private-equity backers (General Atlantic and Hellman & Friedman) of the remaining Emdeon ownership stake held, theretofore, by HLTH Corp. (itself soon to be integrated within WebMD). Emdeon has shelf-registed a potential $460MM IPO with the SEC, and has indicated both that some of the proceeds of the offering will be directed toward further acquisitions; and, that its current private-equity controllers will continue to retain controlling interest of the company after the IPO. A considerable chunk of Emdeon's corporate 'DNA' traces back to the formation of Envoy Corporation here, more than 20 years ago, by Fred Goad, who now partners with former Envoy exec Jim Kever in Brentwood-based Voyent Partners, through which the pair invests in angel and private-equity deals.

NEWSBITS April 20, 2009

Innova, Petra Capital, Fred Goad (Voyent), Al Gore, health IT, BioFuels startup, echo down celljournalist up, tech-transfer event, VCs on VCs... you get the picture, so here are the words.